Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × CP protocol × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 2 Non Small Cell Lung Carcinoma NSCLC 2 Neoplasms 2 Neoplasm Metastasis 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Sarcopenia 1 Penile Neoplasms 1 Non-Small Cell Lung Cancer With HER2- Mutations 1 Malnutrition 1 Male Urogenital Diseases 1 Lung Neoplasms 1 First-line Advanced NSCLC Patients 1 Fallopian Tube Neoplasms 1 Dysgeusia 1 Carcinoma 1

Interventions

fludarabine 4 Cisplatin 4 atezolizumab 3 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 entrectinib 2 durvalumab 2 cobimetinib 2 capmatinib 2 alectinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡